logo

For the Inventor, By the Inventor

South San Francisco, CA, United States of America

Assembly Biosciences, Inc.


USPTO Granted Patents = 14

% Expired Patents = 35.7


Forward Citations = 15

Loading Chart...
Loading Chart...

15 inventors (with patents filed for the assignee):

goldMedal Lee Daniel Arnold (10 out of 10 patents)

silverMedal Hans Maag (9 out of 10 patents)

bronzeMedal Leping Li (8 out of 8 patents)

4.  Mark G Bures (8 out of 8 patents)

5.  Simon Nicolas Haydar (7 out of 7 patents)

6.  William Wilson Turner, Jr (6 out of 16 patents)

7.  Samson Francis (5 out of 6 patents)

8.  William W Turner (4 out of 17 patents)

9.  Roopa Rai (3 out of 3 patents)

10.  Lynne Canne Bannen (3 out of 27 patents)

11.  Michael Walker (3 out of 3 patents)

12.  Adam Zlotnick (2 out of 8 patents)

13.  Sreenivasa Reddy Mundla (1 out of 1 patent)

14.  Thilo J Heckrodt (1 out of 53 patents)

15.  Min Zhong (1 out of 1 patent)


14 patents:

1. 12655130 - 5-MEMBERED HETEROARYL CARBOXAMIDE COMPOUNDS FOR TREATMENT OF HBV (2026-06-16),
2. 12030869 - 5-membered heteroaryl carboxamide compounds for treatment of HBV (2024-07-09),
3. 11814376 - Hepatitis b core protein modulators (2023-11-14),
4. 11560370 - 5-membered heteroaryl carboxamide compounds for treatment of HBV (2023-01-24),
5. 11078170 - Cyclic sulfamide compounds and methods of using same (2021-08-03),
6. 11040965 - Process for making Hepatitis B core protein modulators (2021-06-22),
7. 10987360 - Hepatitis B core protein modulators (2021-04-27),
8. 10968211 - Hepatitis B core protein modulators (2021-04-06),
9. 10947224 - Hepatitis B core protein allosteric modulators (2021-03-16),
10. 10766890 - Hepatitis B core protein modulators (2020-09-08),
11. 10392379 - Hepatitis B core protein modulators (2019-08-27),
12. 10377748 - Hepatitis B core protein modulators (2019-08-13),
13. 10273228 - Hepatitis B viral assembly effectors (2019-04-30),
14. 10183936 - Hepatitis B core protein allosteric modulators (2019-01-22),
Company Overview
Assembly Biosciences, Inc. is a biotechnology company based in South San Francisco, California, focused on developing innovative therapies for viral infections, particularly hepatitis B. The company specializes in advancing its proprietary core inhibitor platform, which aims to disrupt the lifecycle of the hepatitis B virus. Through its research and development efforts, Assembly Biosciences seeks to address significant unmet medical needs in the field of infectious diseases, leveraging cutting-edge science to improve patient outcomes.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

14 Patents

#81 in South San Francisco, CA

#5,317 in California

#22,302 in US

#42,199 in the World

South San Francisco, CA (US)
South San Francisco, CA, United States of America

Assembly Biosciences, Inc.

Forward Citations = 15

15 inventors:

goldMedal Lee Daniel Arnold (10 out of 10 patents)

silverMedal Hans Maag (9 out of 10 patents)

bronzeMedal Leping Li (8 out of 8 patents)

4.  Mark G Bures (8 out of 8 patents)

5.  Simon Nicolas Haydar (7 out of 7 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Assembly Biosciences, Inc.. Retrieved from https://idiyas.com/company/assembly-biosciences

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…